Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.94 USD | -0.65% | +1.24% | -31.84% |
06-04 | Amphastar Pharmaceuticals, Inc. Approves the Appointment of Howard Lee as Director | CI |
06-04 | Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.84% | 2.06B | |
+41.04% | 750B | |
+34.11% | 606B | |
-6.52% | 356B | |
+17.95% | 326B | |
+5.36% | 286B | |
+17.85% | 246B | |
-3.35% | 213B | |
+10.78% | 213B | |
+1.88% | 167B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals : Wells Fargo Downgrades Amphastar Pharmaceuticals to Equal-Weight From Overweight; Price Target is $21